Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prednisone Acetate”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Post-approval studies (Phase 4)Ended earlyNCT00203047
What this trial is testing

Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 414
Large-scale testing (Phase 3)Study completedNCT01591122
What this trial is testing

Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 313
Testing effectiveness (Phase 2)Study completedNCT01023061
What this trial is testing

Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage II Prostate CancerStage III Prostate Cancer+1 more
University of Washington 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03360721
What this trial is testing

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma Without Neuroendocrine DifferentiationStage IV Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT01946165
What this trial is testing

Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 69
Testing effectiveness (Phase 2)Study completedNCT01751451
What this trial is testing

3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 124
Early research (Phase 1)Study completedNCT01400555
What this trial is testing

A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate NeoplasmsProstate Cancer
Cougar Biotechnology, Inc. 22
Large-scale testing (Phase 3)Active Not RecruitingNCT03748641
What this trial is testing

Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

Who this might be right for
Castration-Resistant Prostatic Cancer
Janssen Research & Development, LLC 765
Large-scale testing (Phase 3)Active Not RecruitingNCT05288166
What this trial is testing

Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

Who this might be right for
Prostatic NeoplasmsNeoplasm MetastasisUrogenital Neoplasms+14 more
Eli Lilly and Company 925
Testing effectiveness (Phase 2)Study completedNCT01867710
What this trial is testing

Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy

Who this might be right for
Prostate Cancer
Janssen Pharmaceutica N.V., Belgium 164
Testing effectiveness (Phase 2)Study completedNCT00474383
What this trial is testing

An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Who this might be right for
Prostate Neoplasms
Cougar Biotechnology, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT02928432
What this trial is testing

SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone

Who this might be right for
Prostate Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III 26
Testing effectiveness (Phase 2)Ended earlyNCT04556617
What this trial is testing

PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Opna Bio LLC 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05689021
What this trial is testing

CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Mayo Clinic 8
Testing effectiveness (Phase 2)Study completedNCT02217566
What this trial is testing

Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 46
Not applicableUnknownNCT04129983
What this trial is testing

Treatment of Sudden Deafness With Prednisone+Hyperbaric Oxygen and Prednisone+Somatosensory Stimulation

Who this might be right for
Hearing Loss, SuddenPrednisone AcetateHyperbaric Oxygen+1 more
Dan Su 60
Testing effectiveness (Phase 2)Study completedNCT01381874
What this trial is testing

Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Who this might be right for
Metastatic ER+ Her2- Breast CancerPostmenopausal
Janssen Research & Development, LLC 297
Early research (Phase 1)Active Not RecruitingNCT02913196
What this trial is testing

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Who this might be right for
Prostate Cancer Metastatic
Weill Medical College of Cornell University 16
Testing effectiveness (Phase 2)Study completedNCT01424930
What this trial is testing

Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate NeoplasmsProstate Cancer
Janssen-Ortho Inc., Canada 25
Testing effectiveness (Phase 2)Looking for participantsNCT02960022
What this trial is testing

Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Who this might be right for
Prostate Cancer
Astellas Pharma Global Development, Inc. 900
Load More Results